Ketamine for Treatment-Resistant Depression

• Utgivningsdatum: 2020-09-18
• Mått: 191 x 235 x 13 mm
• Vikt: 360 g
• Format: Häftad
• Språk: Engelska
• Antal sidor: 168
• Förlag: Elsevier Science
• ISBN: 9780128210338

• Biovetenskap

Gustavo H. Vazquez is a Full Professor at the School of Medicine, Queen's University, Director of the CME and staff member of the Mood Disorders Research and Treatment Service, Department of Psychiatry, Providence Care Hospital, Kingston, ON, Canada. He is a member of the Centre for Neuroscience Studies (CNS) at Queen's University (Kingston, Canada), member of the Centre of Neurosicence at Palermo University (Buenos Aires, Argentina) and member of the International Consortium for Psychotic and Bipolar Disorders Research at McLean Hospital, Harvard Medical School (Boston, United States of America). Carlos A. Zarate, MD, is Chief of the Experimental Therapeutics and Pathophysiology Branch at the National Institute of Mental Health. He is a fellow of the American College of Neuropsychopharmacology and member of the Society of Biological Psychiatry and the Society for Neuroscience. Dr. Zarate’s research focuses on the pathophysiology and development of novel therapeutics for treatment-resistant mood disorders as well as the study of biomarkers and neural correlates of treatment response.Elisa Brietzke is a Psychiatrist and Professor at the Department of Psychiatry of Queen's University School of Medicine in Kingston, ON, Canada. She is attending psychiatrist at the Inpatient Unit from Kingston General Hospital and at Mood Disorders Research and Treatment Unit at Providence Care Hospital, both in Kingston, ON, Canada. Dr. Brietzke is also a member of the Centre for Neuroscience Studies (CNS) at Queen's University. She is a member of the Board of Councillors from the International Society of Bipolar Disorders (ISBD). The focus of her research is neurobiology and innovative interventions on mood disorders. She was awarded by a L'Oreal For Women in Science Award 2015 for her work on premature aging and inflammation in mood disorders.

"This is the first book that specifically focuses on ketamine for treatment-resistant depression. This topic has been covered in lectures, articles, and briefly in some textbooks, but this is the first book I have read that specifically covers it. Given the limited available data, the book succeeds in its stated goal to inform readers about what is currently known about ketamine. Updated editions will be needed to reflect the growing knowledge base and eventual treatment strategies using ketamine." --© Doody’s Review Service, 2020, Aaron Plattner, MD(Pine Rest Christian Mental Health Services), reviewer, expert opinion

0 recensioner

Inga recensioner tillgängliga.